A new research paper was published in Genes & Cancer on February 5, 2024, entitled, “Roles of USP1 in Ewing sarcoma.”
Everest Medicines receives NMPA approval for IgAN therapy
Share this article China’s NMPA has approved Nefecon to treat primary immunoglobulin A nephropathy in adult patients. Credit: Pixel-Shot / Shutterstock.com. Everest Medicines has received